Picture of Japan Tissue Engineering Co logo

7774 Japan Tissue Engineering Co Share Price

0.000.00%
jp flag iconLast trade - 00:00
HealthcareAdventurousSmall CapMomentum Trap

Momentum

Relative Strength (%)
1m+10.97%
3m+24.3%
6m+1.17%
1yr-9.1%
Volume Change (%)
10d/3m+105.65%
Price vs... (%)
52w High-20.47%
50d MA+4.37%
200d MA+16.43%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)1.55%
Valuation (ttm)IndustryMarket
Price to Book Value4.45
Price to Tang. Book4.53
Price to Free Cashflown/a
Price to Sales11.03
EV to EBITDAn/a

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-2.62%
Return on Equity-2.64%
Operating Margin-6.54%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202431st Mar 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Japan Tissue Engineering Co EPS forecast chart

Profile Summary

Japan Tissue Engineering Co Ltd is a Japan-based company mainly engaged in regenerative medicine product business, regenerative medicine outsourcing business, and research and development support business. The Company operates through three segments. The Regenerative Medicine Product segment develops regenerative medicine products using tissue engineering, and manufactures and sells the products for medical institutions. The regenerative medicine products include autologous cultured epidermis JACE, and autologous cultured cartilage JACK. The Regenerative Medicine Outsourcing segment provides contract development and manufacturing organization (CDMO) services, contract research organization (CRO) services, consulting services, and contract manufacturing services for specific cell processed products. The Research and Development Support segment manufactures and sells human cultured tissues that apply advanced culture technology accumulated through the development of in-house products.

Directors

Last Annual
March 31st, 2023
Last Interim
December 31st, 2023
Incorporated
February 1st, 1999
Public Since
December 21st, 2007
No. of Shareholders
11,201
No. of Employees
215
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
jp flag iconTokyo Stock Exchange
Shares in Issue
40,609,954

7774 Share Price Performance

Upcoming Events for 7774

Full Year 2024 Japan Tissue Engineering Co Ltd Earnings Release

Similar to 7774

Picture of Alfresa Holdings logo

Alfresa Holdings

jp flag iconTokyo Stock Exchange

Picture of Asahi Intecc Co logo

Asahi Intecc Co

jp flag iconTokyo Stock Exchange

Picture of Aso International logo

Aso International

jp flag iconTokyo Stock Exchange

Picture of As One logo

As One

jp flag iconTokyo Stock Exchange

Picture of Atect logo

Atect

jp flag iconTokyo Stock Exchange

FAQ